Jacobs Levy Equity Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-40,942
Closed -$8.42M 1082
2022
Q4
$8.42M Sell
40,942
-1,845
-4% -$466K 0.06% 305
2022
Q3
$11.9M Buy
+42,787
New +$10.9M 0.09% 231
2022
Q1
Sell
-51,747
Closed -$9.23M 1101
2021
Q4
$9.23M Buy
51,747
+3,890
+8% +$767K 0.06% 322
2021
Q3
$9.85M Buy
47,857
+24,186
+102% +$4.75M 0.07% 299
2021
Q2
$4.49M Buy
+23,671
New +$3.87M 0.03% 452

Other funds holding SWAV

Jacobs Levy Equity Management's SWAV Position: Q1 2023 in Review

Jacobs Levy Equity Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 40,942 shares — an estimated $8.42M sold.

Jacobs Levy Equity Management first reported a position in SWAV in Q2 2021 and held it in 5 quarters. The position peaked at $11.9M in Q3 2022. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

  • Jacobs Levy Equity Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 40,942 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $8.42M.
  • Jacobs Levy Equity Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Jacobs Levy Equity Management's Shockwave Medical, Inc. Common Stock position peaked at $11.9M in Q3 2022.
  • 381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2023, filed 15 May 2023.